Skip to Main Content
Boston Skyline at early morning

2017 Biomanufacturing Summit

Hosted by the Biomanufacturing Science and Technology Consortium (BSTC), Massachusetts BioManufacturing Center (MBMC) and UMass Lowell.

Important Dates: Please mark your calendars. We look forward to meeting you at the summit.

  • May 22-23, 2017: Summit on “Beyond mAbs”
  • May 24-26, 2017: Training on Advanced Industrial Bioprocessing

Location: UMass Club, 1 Beacon Street, Boston, Mass.

Theme: Beyond Monoclonal Antibodies

  • Session 1: Cell therapeutic Dev. and Manufacturing – Advances and Challenges
  • Session 2: Regulatory Sciences, Standardization and Workforce Development
  • Session 3: Protein therapeutics Dev. and Manufacturing – Advances and Challenges
  • Session 4: Gene therapeutics Dev. and Manufacturing – Advances and Challenges

In addition, the following area of interest will be discussed:

  • Emerging Technology and New Therapeutics
  • Regulatory Sciences and Standardization
  • Industry Practices and New Trends in PAT, QbD, Quality Metrics, and Process Validation
  • Integrated Continuous Manufacturing
  • Systems, Synthetic Biology in Biomanufacturing

Online Registration

Who will be participating?

Biomanufacturing Summit 2017 will mark the sixth annual event of the Biomanufacturing Science and Technology Consortium. Expected summit participants are scientists and engineers from bio-pharmaceutical manufacturers, technology/system providers, raw material suppliers and agencies in the areas of development, manufacturing, and engineering. We hope professionals and leaders of biopharmaceutical industry will be able to get together and talk about future biomanufacturing challenges and breakthrough technology. It will also be a great chance to network with professionals from major bio-pharmaceutical manufacturers and various technology providers such as Biogen Idec, Genzyme, Pfizer, Momenta, Millipore, BMS, GE, SAFC and many more.

Featured Speakers

Plenary Speakers

  • Morrey Atkinson, Ph.D., VP of Biologics Development, BMS
  • Lucinda Buhse, Ph.D., Director of OTR, OPQ / CDER / FDA

Session Speakers

  • Julie Murrell, Head, Cell Therapy Bioprocessing, MilliporeSigma
  • Caroline Dugopolski, VP, Technical Operations, Histogenics
  • Karen Nichols, Chief Regulatory Officer, ISCT
  • Yu-Kyeong Hwang, R&D Head, Green Cross LabCell
  • Kelvin Lee, Professor, NIIMBL Director, University of Delaware
  • Sean Bermingham, VP, Life Sciences and Prinipal Consultant, PSE Enterprise Inc.
  • Mark Bruso, Manager, Labor Market Reearch, Massbio
  • Tom Bollenback, Chief Technology Officer, Advanced Regenerative Manufacturing Institute
  • Cyrus Agarabi, Regulatory Research Officer, OBP / FDA/ CDER/DBR II
  • Armin Opitz, Sr. Process Engineer, Sanofi
  • Palani Palaniappan, Head, Biologics & New Modalities Development, Pharmaceutical Sciences,Takeda
  • Joseph Shiloach, Director, Biotechnology Core Laboratory, NIDDK / NIH
  • Roger Hart, Scientific Director, Drug Substance Process Development, Amgen
  • Dr. Mark Klempner, Executive Vice-Chancellor, MassBiologics & Professor,UMass Medical School
  • Ying Jing, Sr. Director of Cell-line and Cell Culture, Dimensiontx
  • Paul Fleming, Sr. Project Manager, Lonza Biologics
  • Michael McCaman, VP, Process Sciences, Intellia Therapeutics
  • David Dismuke, Director, Vector Production, Voyager Therapeutics, Inc

In addition, 20-30 Posters by graduate students and researchers of bio-manufacturing consortium will be presented.

Summit Chair:

  • Jack Prior, Sr. Director, Global MS&T, Sanofi (Chair)
  • John Pieracci, Director, Technology Development, Biogen (co-chair)

Session Chair:

  • Alan Gilbert, Ph.D., Cell-Culture Development, Biogen
  • Cyrus Agarabi, Ph.D./MBA/PharmD, FDA/CDER/OBP
  • Jack Prior, Ph.D., Sr. Director, Global MS&T, Sanofi
  • Meisam Bakhshayeshi, Manager, Technical Development, Biogen

Summit Scientific and Organizing Committee:

  • Seongkyu Yoon, Associate Professor of Chemical Engineering, University of Massachusetts Lowell
  • Carl Lawton, Associate Professor of Chemical Engineering, University of Massachusetts Lowell
  • Jin Xu, Associate Professor of Chemistry, University of Massachusetts Lowell
  • Hyunmin Yi, Associate Professor of Chemical and Biological Engineering, Tufts University
  • Sadettin Ozturk, Ph.D., Mass Biologics, Head of Development and Analytical Technology
  • Rajesh Beri, Head, Mammalian Manufacturing R&D, Lonza Biologics, Portmouth, NH
  • Thomas Ryll, VP, Immunogen
  • Jack Prior, Sr. Director, Global MS&T, Sanofi
  • Tom Porter, Sr. Director of Analytical Research & Development, Global Biologics, Pfizer
  • John Ruesch, Dr. Director of Technology Development, Biogen
  • Anurag Khetan, Site Director, BMS
  • Rashmi Kshirsagar, Director, Technology Development, Biogen
  • Dongming Xie, Associate Professor of Chemical Engineering, University of Massachusetts Lowell
  • Michael S. Tith, Director of Advancement, University of Massachusetts Lowell
  • Arlene R. Parquette, Director of Innovation Institute, University of Massachusetts Lowell

Organizing Staff:

  • Prokash Paul, University of Massachusetts Lowell
  • Ketki Behere, University of Massachusetts Lowell
  • Sha Sha, University of Massachusetts Lowell
  • Hemlata Bhatia, University of Massachusetts Lowell